0.00Open0.00Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover464.12%IV-206.75%PremiumDec 20, 2024Expiry Date23.59Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9649Delta0.0132Gamma0.48Leverage Ratio-0.0371Theta-0.0029Rho-0.47Eff Leverage0.0010Vega
National Vision Stock Discussion
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
• $AutoZone (AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy (CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision (EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $Fresenius Medical Care (FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab (GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
$Oracle (ORCL.US)$ – Oracle surged 12% in premarket trading after reporting better-than-expected profit and revenue for its latest quarter. Oracle is seeing strong dema...
No comment yet